- Home
- DKNG vs BNTX Comparison
DKNG vs BNTX Comparison
Compare DKNG & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DKNG
- BNTX
- Stock Information
- Founded
- DKNG N/A
- BNTX 2008
- Country
- DKNG United States
- BNTX Germany
- Employees
- DKNG N/A
- BNTX N/A
- Industry
- DKNG Services-Misc. Amusement & Recreation
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DKNG Consumer Discretionary
- BNTX Health Care
- Exchange
- DKNG Nasdaq
- BNTX Nasdaq
- Market Cap
- DKNG 26.1B
- BNTX 25.0B
- IPO Year
- DKNG N/A
- BNTX 2019
- Fundamental
- Price
- DKNG $35.88
- BNTX $95.81
- Analyst Decision
- DKNG Strong Buy
- BNTX Strong Buy
- Analyst Count
- DKNG 24
- BNTX 18
- Target Price
- DKNG $54.83
- BNTX $142.27
- AVG Volume (30 Days)
- DKNG 10.7M
- BNTX 896.4K
- Earning Date
- DKNG 05-08-2025
- BNTX 05-05-2025
- Dividend Yield
- DKNG N/A
- BNTX N/A
- EPS Growth
- DKNG N/A
- BNTX N/A
- EPS
- DKNG N/A
- BNTX N/A
- Revenue
- DKNG $5,001,509,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- DKNG $34.34
- BNTX N/A
- Revenue Next Year
- DKNG $19.89
- BNTX $9.07
- P/E Ratio
- DKNG N/A
- BNTX N/A
- Revenue Growth
- DKNG 22.86
- BNTX 0.61
- 52 Week Low
- DKNG $28.69
- BNTX $76.53
- 52 Week High
- DKNG $53.61
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- DKNG 51.87
- BNTX 46.34
- Support Level
- DKNG $34.17
- BNTX $96.38
- Resistance Level
- DKNG $36.00
- BNTX $100.48
- Average True Range (ATR)
- DKNG 1.12
- BNTX 3.44
- MACD
- DKNG -0.07
- BNTX 0.24
- Stochastic Oscillator
- DKNG 36.54
- BNTX 40.84
About DKNG DraftKings Inc.
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number two or three revenue share position across states in which it competes. DraftKings is now live with online or retail sports betting in about 30 states and iGaming in seven states, with both products available to around 40% of Canada's population. The company also operates a non-fungible token commissioned-based marketplace and develops and licenses online gaming products.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.